Literature DB >> 32258239

Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide.

Sebastian Schade1, Brit Mollenhauer2,3, Claudia Trenkwalder2,4.   

Abstract

Entities:  

Keywords:  LED; levodopa equivalent dose; opicapone; safinamide

Year:  2020        PMID： 32258239      PMCID： PMC7111582          DOI： 10.1002/mdc3.12921

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  5 in total

Review 1.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Are There Benefits in Adding Catechol-O Methyltransferase Inhibitors in the Pharmacotherapy of Parkinson's Disease Patients? A Systematic Review.

Authors:  Irene Katsaiti; John Nixon
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

Review 3.  Safinamide: an add-on treatment for managing Parkinson's disease.

Authors:  Thomas Müller
Journal:  Clin Pharmacol       Date:  2018-04-05

Review 4.  Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.

Authors:  Alberto J Espay; Fernando L Pagan; Benjamin L Walter; John C Morgan; Lawrence W Elmer; Cheryl H Waters; Pinky Agarwal; Rohit Dhall; William G Ondo; Kevin J Klos; Dee E Silver
Journal:  Neurol Clin Pract       Date:  2017-02

5.  Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions.

Authors:  J J Ferreira; A Lees; J-F Rocha; W Poewe; O Rascol; P Soares-da-Silva
Journal:  Eur J Neurol       Date:  2019-03-25       Impact factor: 6.089
  5 in total
  27 in total

1.  Short- and long-term motor outcome of STN-DBS in Parkinson's Disease: focus on sex differences.

Authors:  Nico Golfrè Andreasi; Luigi Michele Romito; Roberta Telese; Roberto Cilia; Antonio Emanuele Elia; Alessio Novelli; Giovanni Tringali; Giuseppe Messina; Vincenzo Levi; Grazia Devigili; Sara Rinaldo; Angelo Amato Franzini; Roberto Eleopra
Journal:  Neurol Sci       Date:  2021-09-09       Impact factor: 3.307

Review 2.  Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance.

Authors:  Dag Nyholm; Wolfgang H Jost
Journal:  Ther Adv Neurol Disord       Date:  2022-06-26       Impact factor: 6.430

3.  A study of turn bias in people with idiopathic Parkinson's disease.

Authors:  Lakshmi Pillai; Aliyah Glover; Tuhin Virmani
Journal:  Exp Brain Res       Date:  2022-05-12       Impact factor: 2.064

4.  Impaired Touchscreen Skills in Parkinson's Disease and Effects of Medication.

Authors:  Joni De Vleeschhauwer; Sanne Broeder; Luc Janssens; Elke Heremans; Alice Nieuwboer; Evelien Nackaerts
Journal:  Mov Disord Clin Pract       Date:  2021-03-12

5.  Altered Inhibitory Mechanisms in Parkinson's Disease: Evidence From Lexical Decision and Simple Reaction Time Tasks.

Authors:  Alban Letanneux; Jean-Luc Velay; François Viallet; Serge Pinto
Journal:  Front Hum Neurosci       Date:  2021-04-26       Impact factor: 3.169

6.  Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson's Disease.

Authors:  Linlin Han; Jiaying Lu; Yilin Tang; Yun Fan; Qisi Chen; Ling Li; Fengtao Liu; Jian Wang; Chuantao Zuo; Jue Zhao
Journal:  Front Aging Neurosci       Date:  2021-02-16       Impact factor: 5.750

7.  Predictors of clinically significant quality of life impairment in Parkinson's disease.

Authors:  Diego Santos García; Teresa de Deus Fonticoba; Carlos Cores; Guillermo Muñoz; Jose M Paz González; Cristina Martínez Miró; Ester Suárez; Silvia Jesús; Miquel Aguilar; Pau Pastor; Lluis Planellas; Marina Cosgaya; Juan García Caldentey; Nuria Caballol; Inés Legarda; Jorge Hernández Vara; Iria Cabo; Luis López Manzanares; Isabel González Aramburu; María A Ávila Rivera; Maria J Catalán; Víctor Nogueira; Víctor Puente; María Ruíz de Arcos; Carmen Borrué; Berta Solano Vila; María Álvarez Sauco; Lydia Vela; Sonia Escalante; Esther Cubo; Francisco Carrillo Padilla; Juan C Martínez Castrillo; Pilar Sánchez Alonso; Maria G Alonso Losada; Nuria López Ariztegui; Itziar Gastón; Pedro Clavero; Jaime Kulisevsky; Marta Blázquez Estrada; Manuel Seijo; Javier Rúiz Martínez; Caridad Valero; Mónica Kurtis; Oriol de Fábregues; Jessica González Ardura; Carlos Ordás; Luis M López Díaz; Darrian McAfee; Pablo Martinez-Martin; Pablo Mir
Journal:  NPJ Parkinsons Dis       Date:  2021-12-16

8.  Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study.

Authors:  Diego Santos García; Carmen Labandeira Guerra; Rosa Yáñez Baña; Maria Icíar Cimas Hernando; Iria Cabo López; Jose Manuel Paz Gonález; Maria Gemma Alonso Losada; María José González Palmás; Cristina Martínez Miró
Journal:  Brain Sci       Date:  2021-03-02

9.  Predicting the longitudinal changes of levodopa dose requirements in Parkinson's disease using item response theory assessment of real-world Unified Parkinson's Disease Rating Scale.

Authors:  Dongwoo Chae; Su Jin Chung; Phil Hyu Lee; Kyungsoo Park
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-05-03

10.  Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up.

Authors:  Diego Santos García; Lucía Naya Ríos; Teresa de Deus Fonticoba; Carlos Cores Bartolomé; Lucía García Roca; Maria Feal Painceiras; Cristina Martínez Miró; Hector Canfield; Silvia Jesús; Miquel Aguilar; Pau Pastor; Marina Cosgaya; Juan García Caldentey; Nuria Caballol; Inés Legarda; Jorge Hernández Vara; Iria Cabo; Lydia López Manzanares; Isabel González Aramburu; María A Ávila Rivera; Víctor Gómez Mayordomo; Víctor Nogueira; Víctor Puente; Julio Dotor; Carmen Borrué; Berta Solano Vila; María Álvarez Sauco; Lydia Vela; Sonia Escalante; Esther Cubo; Francisco Carrillo Padilla; Juan C Martínez Castrillo; Pilar Sánchez Alonso; Maria G Alonso Losada; Nuria López Ariztegui; Itziar Gastón; Jaime Kulisevsky; Marta Blázquez Estrada; Manuel Seijo; Javier Rúiz Martínez; Caridad Valero; Mónica Kurtis; Oriol de Fábregues; Jessica González Ardura; Ruben Alonso Redondo; Carlos Ordás; Luis M López Díaz; Darrian McAfee; Pablo Martinez-Martin; Pablo Mir
Journal:  Diagnostics (Basel)       Date:  2021-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.